Search results
Boston Scientific (BSX) Rides on Emerging Markets, MedSurg
Zacks via Yahoo Finance· 12 hours agoBoston Scientific's (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand...
Boston Scientific Corp. (BSX): A Technical Analysis – News Heater
NewsHeater· 4 days agoBoston Scientific Corp. (NYSE: BSX) has a higher price-to-earnings ratio of 62.37x compared to its average ratio. Boston Scientific Corp. (NYSE: BSX)’s ...
If You Invested $100 In This Stock 10 Years Ago, You Would Have $600 Today - Boston Scientific...
Benzinga· 1 day agoBoston Scientific BSX has outperformed the market over the past 10 years by 8.59% on an annualized basis producing an average annual return of 19.33%. Currently, Boston Scientific ...
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
Zacks via Yahoo Finance· 3 days agoShares of Boston Scientific Corporation BSX scaled a new 52-week high of $74.94 on May 17, before...
Boston Scientific (BSX) mCRM System Study Outcome Favorable
Zacks via Yahoo Finance· 3 days agoBoston Scientific Corporation BSX recently presented favorable six-month results from the ongoing...
What Drove A Nearly 2x Rise In Boston Scientific’s Profits?
Forbes· 2 days agoBoston Scientific (NYSE: BSX) saw its net income expand by $0.9 billion or 145% y-o-y to $1.6 billion in 2023. This can primarily be attributed to an expansion of its operating ...
Centene (CNC), Cityblock Partner to Enhance Value-Based Care
Zacks via Yahoo Finance· 9 hours agoMEDP, Boston Scientific Corporation BSX and DaVita Inc. DVA. While Medpace sports a Zacks Rank #1...
DaVita Gains 34.5% YTD: What's Driving the Stock? - Boston Scientific (NYSE:BSX), Align Tech...
Benzinga· 2 days agoShares of the company rallied 34.5% compared with 11.2% growth of the industry in the same time...
Boston Scientific (NYSE:BSX) PT Raised to $90.00 at Mizuho
ETF DAILY NEWS· 7 days agoBoston Scientific (NYSE:BSX – Get Free Report) had its target price increased by equities researchers at Mizuho from $85.00 to $90.00 in a report released on Wednesday, Benzinga ...
Here's Why You Should Retain Inari Medical (NARI) for Now
Zacks· 21 hours agoFree Report) is well-poised for growth, backed by a huge market opportunity for its products and its...